Erdosteine in the Treatment of Nonalcoholic Fatty Liver Disease
NCT07242222
·
clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
RECRUITING
Status
50
Enrollment
OTHER
Sponsor class
Conditions
Fatty Liver
Interventions
OTHER:
Standard Therapy
DRUG:
Erdosteine
Sponsor
Tanta University